RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Legal & General
L

Legal & General (LGIM) portfolio

Legal & General (LGIM) has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Rounds led: 3 of 3.
Capital in their rounds: $107.8M.
Latest deal: Ultromics · Aug 11, 2025.
About this page

It led 3 of the 3 rounds it joined. Its most recent investment on record is Ultromics's $55M Series B+ round in August 2025, which it led, alongside UPMC Enterprises, UCM Ventures, Lightrock and 5 others. By category, its portfolio leans toward Health and bio (1) and Fintech (1). It has co-invested with Blenheim Chalcot, GV and The Blue Venture Fund, most often Blenheim Chalcot (2 rounds).

What Legal & General invests in

Legal & General recent investments

CompanyRoundDateAlongside
UUltromicsSeries B+ · $55M · leadUPMC Enterprises, UCM Ventures, Lightrock (lead) +5
SSalary FinanceSeries B+ · $32.8M · leadFuture Fifty, Blenheim Chalcot (lead)
SSalary FinanceSeries B+ · $20M · leadBlenheim Chalcot (lead)

How Legal & General invests

StageDealsCapital in rounds
Series B+ 3 100%$107.8M
YearDealsCapital in rounds
2018 1 33%$20M
2019 1 33%$32.8M
2025 1 33%$55M

Legal & General portfolio companies

CompanyRound with Legal & GeneralTotal raisedLatest raise
UUltromics
Health and bio
Series B+ · $55M · lead$111MAug 11, 2025
Series B+
SSalary Finance
Fintech
Series B+ · $32.8M · lead$52.8MSep 6, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 3 rounds on Recent Funding that name Legal & General. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Legal & General, which is a subset of its real portfolio. API: /api/v1/investors/legal-general (get a free API key). More: the most active VC firms and new venture capital funds.